Skip to main content
Skip to section navigation
Skip to footer
Home
About
Overview
Management Team
Board of Directors
Advisory Board
Pipeline
Overview
XRx-008 for Autosomal Dominant Polycystic Kidney Disease
XRx-101 for Coronavirus/COVID-19
XRX-225 for Type 2 Diabetic Nephropathy
Publications
Technology
News & Media
Press Releases
Events
In the News
Investors
Overview
News & Events
Presentations
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR
Governance
Contact
News & Events
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Annual & Special Meeting of Shareholders
Email Alerts
Presentations
Company Info
Overview
Management Team
Contacts
FAQ
Financial Info
Overview
Financial Results
Stock Data
Analyst Coverage
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
SEDAR
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Recent News
View All News
March 14, 2023 7:00am EDT
XORTX Announces Type D Meeting with FDA to be held May 1, 2023
February 7, 2023 7:00am EST
XORTX Provides Update on 2022 Achievements and 2023 Planned Milestones
View All News
Upcoming Events
View IR Calendar
May 1, 2023
Type D Meeting
View IR Calendar
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings
Sign Up
Email Alerts
Contacts
RSS News Feed